JACC: CardioOncology Pulse - SGLT2 Inhibitors and Genetics in Cardio-Oncology: What We Can Learn From Our Heart Failure Colleagues
Released: Nov 21, 2023
Dimitrios Farmakis, MD, PhD, and Bonnie Ky, MD, MSCE, discuss SGLT-2 inhibitors and genetics, and applications for cardio-oncology practice.
